These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 65626)

  • 1. Amikacin resistance developing in patients with Pseudomonas aeruginosa bronchopneumonia.
    Amirak ID; Williams RJ; Noone P; Wills MR
    Lancet; 1977 Mar; 1(8010):537-8. PubMed ID: 65626
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin.
    Leung AC; Gribben J; Sleigh JD; Boulton Jones JM
    Scott Med J; 1983 Jan; 28(1):69-70. PubMed ID: 6403983
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Pseudomonas aeruginosa pneumonia with amikacin (author's transl)].
    Izawa T; Katakura K
    Jpn J Antibiot; 1979 Apr; 32(4):532-4. PubMed ID: 110964
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amikacin treatment of septicemia due to gentamicin-resistant gram-negative bacilli (author's transl)].
    Tomioka H; Kobayashi Y; Tamatani S; Morishita T; Hasegawa Y
    Jpn J Antibiot; 1975 Jun; 28(3):305-8. PubMed ID: 807757
    [No Abstract]   [Full Text] [Related]  

  • 6. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.
    Bayer AS; Lam K; Norman D; Kim KS; Morrison JO
    Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin treatment of Pseudomonas-caused corneal ulcer.
    Hansen KD; Meyer RF
    Arch Ophthalmol; 1980 Nov; 98(11):1991-2. PubMed ID: 6776941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amikacin resistance of clinical strains of Enterobacteriaceae and Pseudomonas].
    Moreva TV; Anisimova LA; Erova TE; Boronin AM
    Antibiot Khimioter; 1992 Apr; 37(4):25-8. PubMed ID: 1417311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Kim KS
    Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use.
    Levine JF; Maslow MJ; Leibowitz RE; Pollock AA; Hanna BA; Schaefler S; Simberkoff MS; Rahal JJ
    J Infect Dis; 1985 Feb; 151(2):295-300. PubMed ID: 3918124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
    Mita T; Mayumi K; Kataoka N; Ishigami J
    Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
    [No Abstract]   [Full Text] [Related]  

  • 13. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1981 May; 13(5):1000-3. PubMed ID: 6787072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of amikacin-resistant Pseudomonas aeruginosa developing in patients receiving amikacin.
    Maloney J; Rimland D; Stephens DS; Terry P; Whitney AM
    Arch Intern Med; 1989 Mar; 149(3):630-4. PubMed ID: 2493230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa resistance to ceftazidime.
    Balagué M; Del Valle O; Figueras A; Arnau JM
    DICP; 1991; 25(7-8):871. PubMed ID: 1949952
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of amikacin in pneumology].
    Olivieri D; Cantatore D; Argenziano A; D'Agostino F
    Arch Monaldi; 1980; 35(3):127-33. PubMed ID: 7316662
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefoxitin, amikacin, and Pseudomonas aeruginosa resistance.
    Martinez-Forde JM; Garcia-Caballero J; Aguado-Matorras A
    Lancet; 1982 Sep; 2(8300):719-20. PubMed ID: 6126652
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis.
    Levy J; Baran D; Klastersky J
    J Antimicrob Chemother; 1982 Sep; 10(3):227-34. PubMed ID: 6815155
    [No Abstract]   [Full Text] [Related]  

  • 19. Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Lau WK; Young LS; Osher AB; Dooley RR
    Pediatrics; 1977 Sep; 60(3):372-7. PubMed ID: 408787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
    Mathias RG; Ronald AR; Gurwith MJ; McCullough DW; Stiver HG; Berger J; Cates CY; Fox LM; Lank BA
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-401. PubMed ID: 825590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.